Skip to content

MEDCAP

Dissolved and wound up KBO/BCE: BE 0776.585.562
MEDCAP
Follow Report

Timeline

11 events since 2021
2025
Dissolution with immediate closure of the liquidationDissolved and wound up in a single deed · Director discharge: Scaldino · Director discharge: Quaestum · General meeting of 29-08-20254 points ▸
  • General meeting, 29-08-2025
  • Director discharge, Scaldino
  • Director discharge, Quaestum
  • Director discharge, HP Projects
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2024 filed PDFmicro format · 44 days before the deadline
New directorBV Scaldino appointed, BV B-Epic resigned · Permanent representative: Van Overschelde Philippe · Director discharge: BV B-Epic (director (not named in the articles)) · General meeting of 17-01-20545 points ▸
  • General meeting, 17-01-2054
  • Director resignation, BV B-Epic (director (not named in the articles))
  • Director discharge, BV B-Epic (director (not named in the articles))
  • Director appointment, BV Scaldino (director (not named in the articles))
  • Permanent representative, Van Overschelde Philippe

Open the deed in the Belgian Official Gazette

2024
Back to profit net €123,331 The net result is €123,331, after 2 loss-making years.
Liquidity more than 12 times current ratio 5.22 The current ratio rises from 0.40 to 5.22.
Equity above €150,000 equity €167,719 ▲278% Equity rises from €44,388 to €167,719.
Annual accounts 2023 filed PDFmicro format · 28 days late
2023
Weakest financial year net -€65,207 The net result drops to -€65,207, the lowest from 2022 to 2024.
Annual accounts 2022 filed PDFmicro format · 30 days late
2022
New directorQuaestum appointed, Delta Rho resigned · Issue of 400,000 shares · Permanent representatives: Dimitri Roose and Claikens Bart · General meeting of 22-02-20227 points ▸
  • General meeting, 22-02-2022
  • Auditor report, 21-02-2022
  • Amendment of the articles, article 5
  • Director resignation, Delta Rho
  • Permanent representative, Dimitri Roose
  • Director appointment, Quaestum (director (not named in the articles))
  • Permanent representative, Claikens Bart
  • The deed holds 8 more points.

Open the deed in the Belgian Official Gazette

2021
IncorporationFounding capital of €86,000, €10,000 paid up · Founders: Peerlinck, Hans Marcel Adolf; Goossens, Sander Frans Eliza; Roose, Dimitri Owen Bernard Antoine Oswald; and 3 others · Appointments: HP Projects, Delta Rho and B-Epic16 points ▸
  • Incorporation, 26-10-2021
  • Founder, Peerlinck, Hans Marcel Adolf
  • Founder, Goossens, Sander Frans Eliza
  • Founder, Roose, Dimitri Owen Bernard Antoine Oswald
  • Founder, Bigot, Christian Marie
  • Founder, Claikens, Bart Luc Rik
  • Founder, Van Overschelde, Philippe Peter Cornelius
  • Registered office clause, Kortrijksesteenweg 53/3, 9830 Sint-Martens-Latem
  • Director appointment, HP Projects
  • Director appointment, Delta Rho
  • Director appointment, B-Epic
  • Permanent representative, Peerlinck, Hans Marcel Adolf
  • Permanent representative, Bigot, Christian Marie
  • Permanent representative, Roose, Dimitri Owen Bernard Antoine Oswald
  • Power of attorney, Christian Van Belle
  • Founding capital, €86,000
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

The deed of incorporation of MEDCAP was published in the Belgian Official Gazette on 29 October 2021.1 The board currently has 3 members.2 Total assets rose from €84,855 in 2022 to €207,494 in 2024.3 In 2025 the company was dissolved and its liquidation closed in a single deed.4

  1. 1Belgian Official Gazette, 29-10-2021
  2. 2National Bank, annual accounts 2024
  3. 3National Bank, annual accounts 2022 and 2024
  4. 4Belgian Official Gazette, 22-09-2025

We would like to set cookies. That happens only with your consent. What we measure